Mutations that activate the small GTP-binding protein KRAS are the most common oncogenic event in human tumors. Thirty years after its discovery, mutant KRAS has yet to be therapeutically conquered.

Climbing RAS, the Everest of Oncogenes.

RUSSO, MARIANGELA;DI NICOLANTONIO, Federica;BARDELLI, Alberto
2014

Abstract

Mutations that activate the small GTP-binding protein KRAS are the most common oncogenic event in human tumors. Thirty years after its discovery, mutant KRAS has yet to be therapeutically conquered.
CANCER DISCOVERY
4
1
19
21
http://cancerdiscovery.aacrjournals.org/content/4/1/19.full
KRAS; oncogene
Russo M;Di Nicolantonio F;Bardelli A
File in questo prodotto:
File Dimensione Formato  
Russo_Cancer Discovery-2014-Spotlight.pdf

non disponibili

Tipo di file: PDF EDITORIALE
Dimensione 1.69 MB
Formato Adobe PDF
1.69 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/141961
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 17
social impact